<DOC>
	<DOCNO>NCT02022475</DOCNO>
	<brief_summary>Primary objective -Change Fatigue Assesment Score ( FAS ) first visit ( baseline ) 28 ( +maximum 7 ) day oral administration 100 000 E vitamin D ( Cholecalciferol ) . Secondary objective - Effect oral administration vitamin D serum vitamin D level ( 25-Hydroxy-Vitamin D = Colecalciferol ) , PTH , Calcium , Phosphate compare placebo . - Efficacy vitamin D ( Colecalciferol ) administration fatigue use short self-developed FCA-Test - Safety 100 000 E oral vitamin D ( Colecalciferol ) administration compare oral placebo . Laboratoty parameter serum calzium phosphate level number adverse event compare placebo use safety monitoring . - Efficacy oral administration vitamin D ( Cholecalciferol ) plasma FGF-23 , Sclerostin Klotho level compare placebo .</brief_summary>
	<brief_title>Effect Vitamin D Treatment Fatigue</brief_title>
	<detailed_description>1 . General Design This randomize , double blind , mono-centric , placebo-controlled interventional study effect oral vitamin D supplementation self-reported fatigue . Overall 80 patient proven vitamin D deficiency ( 20-Hydroxy-Vitamin D ≤ 20 µg/L ) fulfill eligibility criterion randomize enrol receive vitamin D placebo 1:1 ratio . All patient must sign informed consent prior enrolment meet eligibility criterion . All patient recruit Medical Outpatients Department University Hospital Zürich . Screening , Part 1 : Consecutive patient consult Medical Outpatients Department , complain fatigue , ask participate study . Basic questionnaire fatigue apply confirm fatigue symptom . Screening , Part 2 : In positive case , patient ask sign inform consent . Beck Depression Inventory ( BDI ) , Mini International Neuropsychiatric Interview ( M.I.N.I . ) Insomnia Severity Index ( ISI ) administer exclude depression , sleep disorder major psychiatric disorder respectively . Thereafter blood test accord table 1 . Patients vitamin D level 20 µg/L undergo randomization . Participants informed result vitamin D level telephone , treatment appointment within 2 week screen arrange participant vitamin D level ≤ 20 µg/L . Visit A ( within 2 week randomisation ) : Routine clinical examination perform . Baseline Fatigue assessment scale ( FAS ) score document , follow blood urine sample accord table 1 measure baseline vitamin D- , PTH- Calcium level . Blood sample undergo centrifugation . Blood urine sample frozen -80°C . Oral Vitamin D preparation placebo administer accord protocol double blind manner . The drug administration do independent person e.g . physician assistant study nurse directly observe drug intake . During administration , procedure implement ensure subject distinguish placebo verum ( identical appearance , taste smell ) . Visit B ( 4 week Visit A + maximum 7 day ) : Patients undergo Assessment Fatigue fill FAS questionnaire . Additionally , short self-developed test Fatigue course assessment ( FCA ) apply evaluate symptomatic response . Thereafter blood urine sample take document biochemical response : Vitamin D- , PTH- , phosphate calcium level . The Vitamin D status subject monitor standard clinical chemical parameter . Safety assessment include pre- post-treatment measurement vital sign , clinical laboratory assessment , record adverse clinical event . 2 . Selection study population / Subject recruitment Patients inform study regular medical visit medical outpatient department USZ . Potential subject provide participant information sheet fill basic questionnaire fatigue . After informed consent obtain , study-specific information collect determine patient meet inclusion criterion without violate exclusion criterion . A total number 80 subject enrol , enrolment goal 12 subject per month . Recruitment take place medical outpatient department ( Klinik und Poliklinik für Innere Medizin ) University Hospital Zurich . If monthly enrolment goal achieve , announcement post university 's announcement board internet page USZ medical department . Patients receive financial compensation . The specific inclusion exclusion criterion enrol subject study describe follow section . 3 . Prior Concomitant Therapy According inclusion/exclusion criterion ( see ) , chronic intake concomitant medication allow , except oral contraceptive . Intake Vitamin D preparation last 8 week start trial protocol trial allow . Vitamin preparation herbal medicine withheld study period . Sporadic medication e.g . NSAID paracetamol symptomatic treatment intercurrent viral infection occasional headache allow . All concomitant medication record CRF . Subjects take additional vitamin D preparation drug study course exclude study . 4 . Randomization blind Overview : A randomization procedure use avoid bias assignment study subject two treatment group ( oral vitamin D , oral placebo ) . Randomization list , preparation study drug placebo , label drug accountability do hospital pharmacy ( Kantonsapotheke Zürich ) . The randomisation list preserve hospital pharmacy . The oral intake directly observe physician assistant study nurse . As placebo verum manufacture identical appearance , taste smell , study participant differ placebo verum . Procedure : Patients assign treatment group base randomization list/schedule prepare hospital pharmacy prior trial . Patients receive randomization number . Randomized patient terminate study participation reason regardless whether study medication take , retain randomization number . The next patient give next randomization number . An Emergency Code Break preserve sealed Emergency Code Envelope available investigator . This envelope Code Break open emergency situation identity investigational product must know investigator order provide appropriate medical treatment . 5 . Treatment / Dosage administration The patient randomize one 2 treatment group ( 40 participant group ) : Group I : oral vitamin D ; Group II : oral placebo . - Group I ( oral vitamin D ) : 100 000 E Vitamin D ( Colecalciferol ) apply single dose two capsule contain 50 000 E . - Group II ( oral placebo ) : 2 placebo capsule apply single dose The drug preparation deliver labelled hospital pharmacy accord standard operating procedure GMP guideline . After study finalisation , placebo group offer treatment Vitamin D. 5 . Study drug information Vitamin D use study 2 capsule contain 50 000 E Cholecalciferol , prepare university hospital pharmacy . Placebo prepare university hospital pharmacy capsule identical appearance , taste smell . 6 . Packing Labeling Study medication ( oral Vitamin D placebo ) provide hospital pharmacy , label package accord Swiss guideline EU-GMP guideline .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>BMI 1825 kg/m2 Serum 25HydroxyVitamin D level &lt; 20 mkg/l Adequate contraception study period Informed consent Anemia Hb level &lt; 120 g/l Known hypersensitivity vitamin D Intake vitamin D preparation ( include ) last 8 week start trial protocol Pregnancy lactation intention become pregnant course study Any cardiovascular , pulmonary , renal hepatic disease Presence muscle disease , CK &gt; 167 U/L Presence know bone disease , alkaline phosphatase &gt; 104 U/l Severe infection/inflammation malignancy Known mental disorder ( e.g . depression ) , sleep disorder Chronic intake concurrent medication , except oral contraceptive . Sporadic intake NSAID paracetamol , e.g . case common cold sporadic headache allow . CRP &gt; 10 mg/l TSH normal range Ferritin &lt; 15 µg/L Any concurrent medical condition ( ) , view investigator , would prevent compliance participation jeopardize health participant . Participation therapeutic trial within previous month Inability follow procedure study , e.g . due language problem , psychological disorder , dementia etc . Enrollment investigator , his/her family member , employee dependent person</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>fatigue</keyword>
</DOC>